Manuel Davila, MD
NPI 1194709626 · Dermatology Physician · Pasadena, TX
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Manuel Davila, MD is a Dermatology Physician provider in Pasadena, TX (NPI 1194709626).
Provider details
- NPI number
- 1194709626
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- L7348 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,221 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,224 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 845 | $96 |
| Destruction of Skin Growth, 1-14 Growths17110 | 698 | $115 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 534 | $39 |
| Biopsy of Related Skin Growth, First Growth11102 | 395 | $62 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 306 | 219 |
| Mupirocin | 252 | 170 |
| Ciclopirox Olaminebrand: Ciclopirox | 244 | 120 |
| Doxycycline Monohydrate | 194 | 108 |
| Clobetasol Propionate | 188 | 118 |
| Ergocalciferol (vitamin D2)brand: Vitamin D2 | 151 | 69 |
| Fluticasone Propionate | 140 | 89 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$6,497 across 300 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-29
- Last updated
- 2022-07-19
- Certified
- 2022-07-19
Frequently asked questions
- What is Manuel Davila's NPI number?
- Manuel Davila's National Provider Identifier (NPI) is 1194709626, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Manuel Davila's specialty?
- Manuel Davila is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Manuel Davila located?
- Manuel Davila's practice location on file with NPPES is 4419 Crenshaw Rd, Pasadena, TX 77504-3628.
- What is Manuel Davila's phone number?
- The practice phone number listed in the NPPES registry for Manuel Davila is (281) 991-5944.
- Does Manuel Davila accept Medicare?
- Manuel Davila is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Manuel Davila's NPI active?
- Yes — Manuel Davila's NPI (1194709626) is active in the NPPES registry as of the last update on 2022-07-19.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.